Clinical trials
Neoplasms trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 5 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 10 |
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 9 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 17 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 155 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 10 |
| Loyola University | 3 |
| Massachusetts General Hospital | 3 |
| American Cancer Society, Inc. | 2 |
| Anthony Magliocco | 2 |
| Blue Note Therapeutics | 2 |
| Caris Science, Inc. | 2 |
| Cedars-Sinai Medical Center | 2 |
| Hennepin Healthcare Research Institute | 2 |
| Oregon Health and Science University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 155 |
| Breast Neoplasms | 17 |
| Neoplasm Metastasis | 15 |
| Prostatic Neoplasms | 11 |
| Pancreatic Neoplasms | 9 |
| Head and Neck Neoplasms | 7 |
| Ovarian Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colonic Neoplasms | 6 |
| Lung Neoplasms | 6 |
Trials
Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.